Alaunos Therapeutics (TCRT) Assets (2009 - 2026)
Alaunos Therapeutics (TCRT) recorded Assets of $1.52 million in Q2 2026, down 68.0% from $4.74 million a year earlier and down 19.5% from the prior quarter.
Powered by 
Analysis
Alaunos Therapeutics (TCRT) Assets (2009 - 2026) Analysis & Trends
At the end of FY2025, Alaunos Therapeutics reported Assets of $2.97 million, up 7.7% from FY2024.
- Annual Assets has a five-year compound annual growth rate of -54.1% (FY2020 to FY2025).
- Across earlier years, Assets came in at $2.76 million in FY2024 (-66.7%), $8.26 million in FY2023 (-87.3%), $64.94 million in FY2022 (-31.5%) and $94.87 million in FY2021 (-35.2%).
- The Q2 2026 figure is the lowest quarterly Assets in data going back to Q4 2009.
- On a year-over-year basis, Assets rose in three of the last eight quarters, with an average decline of 34.8%.
- Peak year-over-year performance for Assets in the last five years was growth of 7.7% in Q4 2025, against a decline of 87.6% in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.88 million (Q1 2026), $2.97 million (Q4 2025) and $3.72 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Alaunos Therapeutics | 2.39 Mn | -1.41 Mn | - | 1.52 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.52 Mn |
| Mar 31, 2026 | 1.88 Mn |
| Dec 31, 2025 | 2.97 Mn |
| Sep 30, 2025 | 3.72 Mn |
| Jun 30, 2025 | 4.74 Mn |
| Mar 31, 2025 | 2.12 Mn |
| Dec 31, 2024 | 2.76 Mn |
| Sep 30, 2024 | 3.55 Mn |
| Jun 30, 2024 | 4.68 Mn |
| Mar 31, 2024 | 6.04 Mn |
| Dec 31, 2023 | 8.26 Mn |
| Sep 30, 2023 | 19.44 Mn |
| Jun 30, 2023 | 27.93 Mn |
| Mar 31, 2023 | 48.64 Mn |
| Dec 31, 2022 | 64.94 Mn |
| Sep 30, 2022 | 67.34 Mn |
| Jun 30, 2022 | 73.93 Mn |
| Mar 31, 2022 | 84.99 Mn |
| Dec 31, 2021 | 94.87 Mn |
| Sep 30, 2021 | 113.76 Mn |
API Access
Alaunos Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=TCRT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "TCRT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=TCRT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();